Bartlett E, Yttredahl A, Boldrini M, Tyrer A, Hill K, Ananth M
Eur Psychiatry. 2023; 66(1):e17.
PMID: 36691786
PMC: 9970152.
DOI: 10.1192/j.eurpsy.2023.4.
Lan M, Zanderigo F, Pantazatos S, Sublette M, Miller J, Ogden R
Int J Neuropsychopharmacol. 2022; 25(7):534-544.
PMID: 34996114
PMC: 9352178.
DOI: 10.1093/ijnp/pyac001.
Shokri-Kojori E, Naganawa M, Ramchandani V, Wong D, Wang G, Volkow N
Hum Brain Mapp. 2021; 43(4):1419-1430.
PMID: 34873784
PMC: 8837588.
DOI: 10.1002/hbm.25733.
Melhem N, Zhong Y, Miller J, Zanderigo F, Ogden R, Sublette M
Int J Neuropsychopharmacol. 2021; 25(1):36-45.
PMID: 34555145
PMC: 8756092.
DOI: 10.1093/ijnp/pyab060.
Marques T, Veronese M, Owen D, Rabiner E, Searle G, Howes O
Eur J Nucl Med Mol Imaging. 2021; 48(11):3530-3539.
PMID: 33825022
PMC: 8440284.
DOI: 10.1007/s00259-021-05327-x.
Examining the underpinnings of loudness dependence of auditory evoked potentials with positron emission tomography.
Pillai R, Bartlett E, Ananth M, Zhu C, Yang J, Hajcak G
Neuroimage. 2020; 213:116733.
PMID: 32169543
PMC: 7254571.
DOI: 10.1016/j.neuroimage.2020.116733.
Prediction of lithium treatment response in bipolar depression using 5-HTT and 5-HT PET.
Ananth M, Bartlett E, DeLorenzo C, Lin X, Kunkel L, Vadhan N
Eur J Nucl Med Mol Imaging. 2020; 47(10):2417-2428.
PMID: 32055965
PMC: 8789023.
DOI: 10.1007/s00259-020-04681-6.
In vivo PET Imaging of [11C]CIMBI-5, a 5-HT2AR Agonist Radiotracer in Nonhuman Primates.
Prabhakaran J, DeLorenzo C, Zanderigo F, Knudsen G, Gilling N, Pratap M
J Pharm Pharm Sci. 2019; 22(1):352-364.
PMID: 31356761
PMC: 7453972.
DOI: 10.18433/jpps30329.
Brain serotonin transporter binding, plasma arachidonic acid and depression severity: A positron emission tomography study of major depression.
Gopaldas M, Zanderigo F, Zhan S, Ogden R, Miller J, Rubin-Falcone H
J Affect Disord. 2019; 257:495-503.
PMID: 31319341
PMC: 6886679.
DOI: 10.1016/j.jad.2019.07.035.
Quantification of Positron Emission Tomography Data Using Simultaneous Estimation of the Input Function: Validation with Venous Blood and Replication of Clinical Studies.
Bartlett E, Ananth M, Rossano S, Zhang M, Yang J, Lin S
Mol Imaging Biol. 2018; 21(5):926-934.
PMID: 30535672
PMC: 6555699.
DOI: 10.1007/s11307-018-1300-1.
In Vivo Brain Imaging, Biodistribution, and Radiation Dosimetry Estimation of [C]Celecoxib, a COX-2 PET Ligand, in Nonhuman Primates.
Dileep Kumar J, Bai B, Zanderigo F, DeLorenzo C, Prabhakaran J, Parsey R
Molecules. 2018; 23(8).
PMID: 30072617
PMC: 6222548.
DOI: 10.3390/molecules23081929.
Kappa opioid receptor binding in major depression: A pilot study.
Miller J, Zanderigo F, Purushothaman P, DeLorenzo C, Rubin-Falcone H, Ogden R
Synapse. 2018; 72(9):e22042.
PMID: 29935119
PMC: 7599086.
DOI: 10.1002/syn.22042.
Statistical evaluation of test-retest studies in PET brain imaging.
Baumgartner R, Joshi A, Feng D, Zanderigo F, Ogden R
EJNMMI Res. 2018; 8(1):13.
PMID: 29435678
PMC: 5809632.
DOI: 10.1186/s13550-018-0366-8.
[C]Harmine Binding to Brain Monoamine Oxidase A: Test-Retest Properties and Noninvasive Quantification.
Zanderigo F, DAgostino A, Joshi N, Schain M, Kumar D, Parsey R
Mol Imaging Biol. 2018; 20(4):667-681.
PMID: 29423903
DOI: 10.1007/s11307-018-1165-3.
A positron emission tomography study of the serotonergic system in relation to anxiety in depression.
Iscan Z, Rakesh G, Rossano S, Yang J, Zhang M, Miller J
Eur Neuropsychopharmacol. 2017; 27(10):1011-1021.
PMID: 28811068
PMC: 5623123.
DOI: 10.1016/j.euroneuro.2017.07.009.
A hybrid deconvolution approach for estimation of in vivo non-displaceable binding for brain PET targets without a reference region.
Zanderigo F, Mann J, Ogden R
PLoS One. 2017; 12(5):e0176636.
PMID: 28459878
PMC: 5411064.
DOI: 10.1371/journal.pone.0176636.
Lack of association between the serotonin transporter and serotonin 1A receptor: an in vivo PET imaging study in healthy adults.
Strupp-Levitsky M, Miller J, Rubin-Falcone H, Zanderigo F, Milak M, Sullivan G
Psychiatry Res Neuroimaging. 2016; 255:81-6.
PMID: 27567324
PMC: 5175477.
DOI: 10.1016/j.pscychresns.2016.08.002.
Positron Emission Tomographic Imaging of the Serotonergic System and Prediction of Risk and Lethality of Future Suicidal Behavior.
Oquendo M, Galfalvy H, Sullivan G, Miller J, Milak M, Sublette M
JAMA Psychiatry. 2016; 73(10):1048-1055.
PMID: 27463606
PMC: 6552665.
DOI: 10.1001/jamapsychiatry.2016.1478.
Measuring specific receptor binding of a PET radioligand in human brain without pharmacological blockade: The genomic plot.
Veronese M, Zanotti-Fregonara P, Rizzo G, Bertoldo A, Innis R, Turkheimer F
Neuroimage. 2016; 130:1-12.
PMID: 26850512
PMC: 4983715.
DOI: 10.1016/j.neuroimage.2016.01.058.
Relationship of the serotonin transporter gene promoter polymorphism (5-HTTLPR) genotype and serotonin transporter binding to neural processing of negative emotional stimuli.
Schneck N, Miller J, DeLorenzo C, Kikuchi T, Sublette M, Oquendo M
J Affect Disord. 2015; 190:494-498.
PMID: 26561939
PMC: 5021308.
DOI: 10.1016/j.jad.2015.10.047.